Cargando…
Celecoxib increases retinoid sensitivity in human colon cancer cell lines
Retinoid resistance has limited the clinical application of retinoids as differentiation-inducing and apoptosis-inducing drugs. This study was designed to investigate whether celecoxib, a selective COX-2 inhibitor, has effects on retinoid sensitivity in human colon cancer cell lines, and to determin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SP Versita
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275995/ https://www.ncbi.nlm.nih.gov/pubmed/20496179 http://dx.doi.org/10.2478/s11658-010-0016-2 |